159 related articles for article (PubMed ID: 35667975)
21. Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.
Widder S; Carmody L; Opron K; Kalikin L; Caverly L; LiPuma J
Res Sq; 2024 Mar; ():. PubMed ID: 38562856
[TBL] [Abstract][Full Text] [Related]
22. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.
de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R
mBio; 2017 Sep; 8(5):. PubMed ID: 28951476
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic duration and changes in FEV
Espel JC; Palac HL; Cullina JF; Clarke AP; McColley SA; Prickett MH; Jain M
BMC Pulm Med; 2017 Nov; 17(1):160. PubMed ID: 29187171
[TBL] [Abstract][Full Text] [Related]
24. Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.
Carmody LA; Caverly LJ; Foster BK; Rogers MAM; Kalikin LM; Simon RH; VanDevanter DR; LiPuma JJ
PLoS One; 2018; 13(3):e0194060. PubMed ID: 29522532
[TBL] [Abstract][Full Text] [Related]
25. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.
Aaron SD; Vandemheen KL; Ferris W; Fergusson D; Tullis E; Haase D; Berthiaume Y; Brown N; Wilcox P; Yozghatlian V; Bye P; Bell S; Chan F; Rose B; Jeanneret A; Stephenson A; Noseworthy M; Freitag A; Paterson N; Doucette S; Harbour C; Ruel M; MacDonald N
Lancet; 2005 Aug 6-12; 366(9484):463-71. PubMed ID: 16084254
[TBL] [Abstract][Full Text] [Related]
26. Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Airway Microbiome Diversity and Pulmonary Function.
Bozzella MJ; Chaney H; Sami I; Koumbourlis A; Bost JE; Zemanick ET; Freishtat RJ; Crandall KA; Hahn A
Pediatr Infect Dis J; 2021 Nov; 40(11):962-968. PubMed ID: 34269323
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site.
Schechter MS; Regelmann WE; Sawicki GS; Rasouliyan L; VanDevanter DR; Rosenfeld M; Pasta D; Morgan W; Konstan MW
Pediatr Pulmonol; 2015 May; 50(5):431-40. PubMed ID: 25530325
[TBL] [Abstract][Full Text] [Related]
28. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.
Harris JK; Wagner BD; Zemanick ET; Robertson CE; Stevens MJ; Heltshe SL; Rowe SM; Sagel SD
Ann Am Thorac Soc; 2020 Feb; 17(2):212-220. PubMed ID: 31604026
[No Abstract] [Full Text] [Related]
29. Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis.
Hahn A; Fanous H; Jensen C; Chaney H; Sami I; Perez GF; Koumbourlis AC; Louie S; Bost JE; van den Anker JN; Freishtat RJ; Zemanick ET; Crandall KA
Sci Rep; 2019 Feb; 9(1):2534. PubMed ID: 30796252
[TBL] [Abstract][Full Text] [Related]
30. Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?
Skolnik K; Nguyen A; Thornton CS; Waddell B; Williamson T; Rabin HR; Parkins MD
BMC Infect Dis; 2017 Oct; 17(1):660. PubMed ID: 28969684
[TBL] [Abstract][Full Text] [Related]
31. Microbiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation.
Twomey KB; Alston M; An SQ; O'Connell OJ; McCarthy Y; Swarbreck D; Febrer M; Dow JM; Plant BJ; Ryan RP
PLoS One; 2013; 8(12):e82432. PubMed ID: 24358183
[TBL] [Abstract][Full Text] [Related]
32. Azithromycin and the microbiota of cystic fibrosis sputum.
Acosta N; Thornton CS; Surette MG; Somayaji R; Rossi L; Rabin HR; Parkins MD
BMC Microbiol; 2021 Mar; 21(1):96. PubMed ID: 33784986
[TBL] [Abstract][Full Text] [Related]
33. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
[TBL] [Abstract][Full Text] [Related]
34. Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis.
Breen P; Zimbric M; Opron K; Caverly LJ
mSphere; 2022 Jun; 7(3):e0010422. PubMed ID: 35477313
[TBL] [Abstract][Full Text] [Related]
35. Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis.
Bouzek DC; Ren CL; Thompson M; Slaven JE; Sanders DB
Pediatr Pulmonol; 2022 Jul; 57(7):1709-1716. PubMed ID: 35429154
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis.
Whelan FJ; Heirali AA; Rossi L; Rabin HR; Parkins MD; Surette MG
PLoS One; 2017; 12(3):e0172811. PubMed ID: 28253277
[TBL] [Abstract][Full Text] [Related]
37. A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation.
Quinn RA; Whiteson K; Lim YW; Salamon P; Bailey B; Mienardi S; Sanchez SE; Blake D; Conrad D; Rohwer F
ISME J; 2015 Mar; 9(4):1024-38. PubMed ID: 25514533
[TBL] [Abstract][Full Text] [Related]
38. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation.
Carmody LA; Zhao J; Schloss PD; Petrosino JF; Murray S; Young VB; Li JZ; LiPuma JJ
Ann Am Thorac Soc; 2013 Jun; 10(3):179-87. PubMed ID: 23802813
[TBL] [Abstract][Full Text] [Related]
39. Refining the Application of Microbial Lipids as Tracers of Staphylococcus aureus Growth Rates in Cystic Fibrosis Sputum.
Neubauer C; Kasi AS; Grahl N; Sessions AL; Kopf SH; Kato R; Hogan DA; Newman DK
J Bacteriol; 2018 Dec; 200(24):. PubMed ID: 30249710
[TBL] [Abstract][Full Text] [Related]
40. High individuality of respiratory bacterial communities in a large cohort of adult cystic fibrosis patients under continuous antibiotic treatment.
Kramer R; Sauer-Heilborn A; Welte T; Jauregui R; Brettar I; Guzman CA; Höfle MG
PLoS One; 2015; 10(2):e0117436. PubMed ID: 25671713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
